This is out Library. Please click on the article title to view the details.
submitted by: admin on 11/24/2019
According to an article published in the April 2013 issue of the journal Internal Medicine, patients on SSRI antidepressants at the time of surgery have a 20% increased mortality, 9% increased risk for bleeding, and 22% increased risk for readmission within a month of discharge from the hospital! This was based on a review of 530,000 surgical patients from...
submitted by: admin on 09/20/2013
The FDA recently approved a drug called Intermezzo for use in the middle of the night wakening that is followed by difficulty returning to sleep. The drug is Ambien, but the dosage is much smaller and the indication is new. Here is another example of a drug company coming up with a novel treatment that treats the symptoms but not the cause. It also has potential...
submitted by: admin on 10/11/2013
Medical marijuana is a valuable asset in treatment, especially in cancer and HIV, but it has legal ramifications. Research objectively documents its value. Delivery systems are discussed. Cannabis is synergistic with opoids.
submitted by: admin on 09/13/2014
In our pharmaceutically oriented culture, antidepressants are often looked as the solution for depression. We want the quickest fix that will get us back on our feet and back to work. And the medical profession has been trained to resort to using antidepressants, especially the SSRI type that include Prosac, Zoloft, Celexa, Lexapro, Paxil, and Luvox rather than...